Venture Capital To Indian Biotechs Lagging This Year
This article was originally published in PharmAsia News
Executive Summary
Venture capital investments in Indian biotechs have dropped, according to a report on the first quarter of this year. Dow Jones VentureSources counted $11 million invested in only two biopharmaceutical deals during that three-month period. Last year, $99.5 million was invested in life sciences and health care companies in India. An official at MPM Capital, which with TPG Ventures, was among early investors in early-stage biotechs in India, says he still expects the number of life sciences deals to grow. (Click here for more